Stain-free digital pathology imaging provides microarchitecturally-resolved insights into scar evolution allowing direct clinical outcome prediction in metabolic dysfunction-associated steatotic liver disease
Presentation ID: OS-087, EASL Congress 2024 ABSTRACT Authors: Timothy Kendall1, Stephen A. Harrison2, Dean Tai3, Elaine Chng3, Yayun Ren3, Jonathan Fallowfield1 1. University of Edinburgh, Edinburgh, United Kingdom 2. Pinnacle Clinical Research, San Antonio, United States 3. HistoIndex Pte. Ltd, Singapore, Singapore Background and Aims: Fibrosis stage in metabolic dysfunction-associated steatotic liver disease (MASLD) is …